Keywords: Roche, Merck & Co, Companion diagnostics, Cancer drugs

Roche and Merck & Co link to develop companion diagnostic for latter’s investigational cancer drugs

Article | 09 June 2011

Print This

In a further collaboration between the companies, US drugs giant Merck & Co (NYSE:MRK) has entered into an agreement ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in